NCT02227420View on ClinicalTrials.gov

Effects of IL-1 Beta on the HPA-axis in Obese Persons

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

July 31, 2016

Conditions
Metabolic SyndromeHypersecretion; Cortisol
Interventions
DRUG

Anakinra

Anakinra 100mg s.c. x 5

Trial Locations (1)

Unknown

University Hopsital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02227420 - Effects of IL-1 Beta on the HPA-axis in Obese Persons | Biotech Hunter | Biotech Hunter